Functional characterization of 22 novel CYP2D6 variants for the metabolism of Tamoxifen

被引:3
作者
Hu, Xiao-Xia [1 ]
Zhou, Quan [1 ]
Lan, Tian [1 ]
Huang, Xiang-Xin [1 ]
Liang, Bing-qing [1 ]
Dai, Da-Peng [2 ,3 ]
Cai, Jian-Ping [2 ,3 ]
Hu, Guo-Xin [1 ]
机构
[1] Wenzhou Med Univ, Sch Pharm, Dept Pharmacol, Wenzhou, Zhejiang, Peoples R China
[2] Beijing Hosp, Key Lab Geriatr, Beijing 100730, Peoples R China
[3] Minist Hlth, Beijing Inst Geriatr, Beijing 100730, Peoples R China
基金
中国国家自然科学基金;
关键词
allelic variants; CYP2D6; polymorphism; drug metabolism; tamoxifen; CYTOCHROME-P450; 2D6; GENETIC POLYMORPHISMS; CHINESE POPULATION; BREAST-CANCER; IN-VITRO; DEXTROMETHORPHAN; CONSEQUENCES; FREQUENCIES; ALLELE; WOMEN;
D O I
10.1111/jphp.12556
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives This study aimed to assess the catalytic characteristics of 24 CYP2D6 allelic isoforms found in Chinese Han population on the metabolism of tamoxifen in vitro. Methods Recombinant CYP2D6 microsomes of distinguished genotypes were used to characterize the corresponding enzyme activity towards tamoxifen. About 5-2500 mu M tamoxifen was incubated for 30 min at 37 degrees C. Using high-performance liquid chromatography to detect the products, the kinetic parameters Km, V-max and intrinsic clearance (V-max/K-m) of N-desmethyltamoxifen were determined. Key findings Of the 24 tested allelic variants, the differences of intrinsic clearance value were shown as follows: CYP2D6.89 was much higher than wild-type CYP2D6.1, 2 allelic isoforms (CYP2D6.88 and D336N) exhibited similar intrinsic clearance values as the wild-type enzyme, two variants displayed weak or no activity, while the rest 19 variants showed significantly reduced intrinsic clearance values ranging from 7.46 to 81.11%. Conclusion The comprehensive assessment of CYP2D6 variants provides significant insights into allele-specific activity towards tamoxifen in vitro, suggesting that most of the carriers of these alleles might be paid more attention when using CYP2D6-mediated drugs clinically.
引用
收藏
页码:819 / 825
页数:7
相关论文
共 25 条
  • [1] Individualization of tamoxifen therapy: Much more than just CYP2D6 genotyping
    Binkhorst, Lisette
    Mathijssen, Ron H. J.
    Jager, Agnes
    van Gelder, Teun
    [J]. CANCER TREATMENT REVIEWS, 2015, 41 (03) : 289 - 299
  • [2] Binding of bufuralol, dextromethorphan, and 3,4-methylenedioxymethylamphetamine to wild-type and F120A mutant cytochrome P450 2D6 studied by resonance Raman spectroscopy
    Bonifacio, A
    Keizers, PHJ
    Commandeur, JNM
    Vermeulen, NPE
    Robert, B
    Gooijer, C
    van der Zwan, G
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 343 (03) : 772 - 779
  • [3] Prediction of tamoxifen outcome by genetic variation of CYP2D6 in post-menopausal women with early breast cancer
    Brauch, Hiltrud
    Schwab, Matthias
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 77 (04) : 695 - 703
  • [4] Effects of the CYP2D6*10 allele on the pharmacokinetics of atomoxetine and its metabolites
    Byeon, Ji-Yeong
    Kim, Young-Hoon
    Na, Han-Sung
    Jang, Jong-Hwa
    Kim, Se-Hyung
    Lee, Yun-Jeong
    Bae, Jung-Woo
    Kim, In Su
    Jang, Choon-Gon
    Chung, Myeon-Woo
    Lee, Seok-Yong
    [J]. ARCHIVES OF PHARMACAL RESEARCH, 2015, 38 (11) : 2083 - 2091
  • [5] Effects of 22 Novel CYP2D6 Variants Found in the Chinese Population on the Bufuralol and Dextromethorphan Metabolisms In Vitro
    Cai, Jie
    Dai, Da-Peng
    Geng, Pei-Wu
    Wang, Shuang-Hu
    Wang, Hao
    Zhan, Yun-Yun
    Huang, Xiang-Xin
    Hu, Guo-Xin
    Cai, Jian-Ping
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 118 (03) : 190 - 199
  • [6] Cronin-Fenton DP, 2014, FUTURE ONCOL, V10, P107, DOI [10.2217/fon.13.168, 10.2217/FON.13.168]
  • [7] ANALYSIS OF THE CYP2D6 GENE IN RELATION TO DEBRISOQUIN AND DESIPRAMINE HYDROXYLATION IN A SWEDISH POPULATION
    DAHL, ML
    JOHANSSON, I
    PALMERTZ, MP
    INGELMANSUNDBERG, M
    SJOQVIST, F
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (01) : 12 - 17
  • [8] In Vitro Functional Assessment of 22 Newly Identified CYP2D6 Allelic Variants in the Chinese Population
    Dai, Da-Peng
    Geng, Pei-Wu
    Wang, Shuang-Hu
    Cai, Jie
    Hu, Li-Ming
    Nie, Jing-Jing
    Hu, Ji-Hong
    Hu, Guo-Xin
    Cai, Jian-Ping
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 117 (01) : 39 - 43
  • [9] Allele and genotype frequencies of polymorphic cytochromes P4502D6, 2C19 and 2E1 in Aborigines from Western Australia
    Griese, EU
    Ilett, KF
    Kitteringham, NR
    Eichelbaum, M
    Powell, H
    Spargo, RM
    LeSouef, PN
    Musk, AW
    Minchin, RF
    [J]. PHARMACOGENETICS, 2001, 11 (01): : 69 - 76
  • [10] Cytochrome P450 and chemical toxicology
    Guengerich, F. Peter
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 2008, 21 (01) : 70 - 83